{
  "buildId": "5lGULuFSFhUrfWgBpMJq_",
  "gssp": true,
  "isFallback": false,
  "page": "/calc/[...slug]",
  "props": {
    "__N_SSP": true,
    "pageProps": {
      "calc": {
        "before_use": "",
        "calc_type": "diagnostic_criteria",
        "chief_complaint_en": [
          "Abdominal Pain",
          "Vomiting"
        ],
        "cmeEndDate": "2025-07-25 00:00:00+00+161",
        "cmeLastReviewed": "2022-07-25 00:00:00+00+161",
        "cmeReleaseDate": "2020-10-08 00:00:00+00+00",
        "cmeVersion": "10130.1",
        "cme_status": "enabled",
        "content": {
          "about": {
            "evidence_based_medicine_en": "<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">The <a href=\"https://onlinelibrary.wiley.com/doi/full/10.1002/jhbp.515\" target=\"_blank\" rel=\"noopener\">Tokyo Guidelines 2018 (TG18)</a> are a revision of the 2013 guidelines (TG13), and incorporate new evidence based on validation studies of TG13.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28419779\" target=\"_blank\" rel=\"noopener\">Yokoe et al (2017)</a> studied 4,360 patients and found that the 30-day overall mortality rate was 1.1% for Grade I, 0.8% for Grade II, 5.4% for Grade III (p &lt;0.001), and the higher the grade, the more likely open surgery would be selected (p &lt;0.001).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26288122\" target=\"_blank\" rel=\"noopener\">Wright et al (2015)</a> studied 445 patients, in the first study validating&nbsp;Tokyo Guidelines&nbsp;in American patients, and found that length of stay (p &lt;0.001), disposition to home (p &lt;0.001), and morbidity (p = 0.003) correlated with increasing TG13 grade.</p>\n</li>\n</ul>",
            "formula_en": "<p dir=\"ltr\"><span id=\"docs-internal-guid-30f7df92-7fff-88cc-e5e1-6f03c7c83b41\">Patient must have a suspected diagnosis (&ge;1 item in A + &ge;1 item in B or C) or definite diagnosis (&ge;1 item in A, B, and C) to meet entry criteria for severity grading, see table below:</span></p>\n<p dir=\"ltr\"><strong>Diagnosis:</strong></p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"173\"><col width=\"275\"></colgroup>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p dir=\"ltr\"><strong>Criteria</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p dir=\"ltr\"><strong>Part A</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p dir=\"ltr\">Local signs of inflammation</p>\n</td>\n<td>\n<p dir=\"ltr\">Murphy's sign</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Right upper abdominal quadrant mass, pain, or tenderness</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p dir=\"ltr\"><strong>Part B</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p dir=\"ltr\">Systemic signs of inflammation</p>\n</td>\n<td>\n<p dir=\"ltr\">Fever</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Elevated CRP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Elevated WBC count</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p dir=\"ltr\"><strong>Part C</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Imaging</p>\n</td>\n<td>\n<p dir=\"ltr\">Imaging findings characteristic of acute cholecystitis*</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p dir=\"ltr\">*e.g. pericholecystic fluid, gallstones/debris.</p>\n<p dir=\"ltr\">&nbsp;</p>\n<p dir=\"ltr\"><strong>Severity grading:</strong></p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"*\"></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Grade III (dysfunction in &ge;1 of the following):</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Cardiovascular dysfunction: hypotension requiring treatment with dopamine &ge;5 &mu;g/kg per min or any dose of norepinephrine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Neurological dysfunction: decreased level of consciousness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Respiratory dysfunction: PaO<sub>2</sub>/FiO<sub>2</sub> ratio &lt;300</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Renal dysfunction: oliguria or creatinine &gt;2.0 mg/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Hepatic dysfunction: <abbr title=\"Prothrombin time - International normalized ratio\">PT‐INR</abbr> &gt;1.5</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Hematological dysfunction: platelet count &lt;100,000/mm<sup>3</sup></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Grade II (&ge;1 of the following conditions):</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Elevated WBC count (&gt;18,000/mm<sup>3</sup>)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Palpable tender mass in the right upper abdominal quadrant</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Duration of complaints &gt;72 hours</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Marked local inflammation (gangrenous cholecystitis, pericholecystic abscess, hepatic abscess, biliary peritonitis, emphysematous cholecystitis)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Grade I</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Acute cholecystitis does not meet the above criteria; no organ dysfunction and mild inflammatory changes in the gallbladder</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p></p>",
            "more_info_en": "<p dir=\"ltr\">Interpretation:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"98\"><col width=\"228\"><col width=\"123\"></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Grade</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Acute cholecystitis severity</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>30day mortality</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">I</p>\n</td>\n<td>\n<p dir=\"ltr\">Mild</p>\n</td>\n<td>\n<p dir=\"ltr\">1.1%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">II</p>\n</td>\n<td>\n<p dir=\"ltr\">Moderate</p>\n</td>\n<td>\n<p dir=\"ltr\">0.8%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">III</p>\n</td>\n<td>\n<p dir=\"ltr\">Severe</p>\n</td>\n<td>\n<p dir=\"ltr\">5.4%</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p><span id=\"docs-internal-guid-4188c02f-7fff-499e-1047-5214fa767c04\"><span id=\"docs-internal-guid-4188c02f-7fff-499e-1047-5214fa767c04\">Note: decrease in mortality for moderate severity is counterintuitive, but reflects limitations in the data.<br></span></span></p>",
            "references_list": {
              "Clinical Practice Guidelines": [
                {
                  "href": "",
                  "text": ""
                }
              ],
              "Manufacturer Website": [
                {
                  "href": "",
                  "text": ""
                }
              ],
              "Original/Primary Reference": [
                {
                  "href": "https://onlinelibrary.wiley.com/doi/full/10.1002/jhbp.515",
                  "text": "Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):41-54."
                }
              ],
              "Other References": [
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/26288122",
                  "text": "Wright GP, Stilwell K, Johnson J, Hefty MT, Chung MH. Predicting length of stay and conversion to open cholecystectomy for acute cholecystitis using the 2013 Tokyo Guidelines in a US population. J Hepatobiliary Pancreat Sci. 2015;22:795-801."
                },
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/28419779",
                  "text": "Yokoe M, Takada T, Hwang TL, Endo I, Akazawa K, Miura F, et al. Validation of TG13 severity grading in acute cholecystitis: Japan‐Taiwan collaborative study for acute cholecystitis. J Hepatobiliary Pancreat Sci. 2017;24:338-45."
                },
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/29090866",
                  "text": "Gomi, H, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:3-16."
                }
              ],
              "Outcomes": [
                {
                  "href": "",
                  "text": ""
                }
              ],
              "Validation": [
                {
                  "href": "",
                  "text": ""
                }
              ],
              "Validations": []
            }
          },
          "contributor": {
            "expert_name": [
              "Joseph Mizrahi, MD"
            ]
          },
          "creator": [
            {
              "approved": null,
              "name": "Dr. Masamichi Yokoe",
              "qa_en": null
            }
          ],
          "how_to_use": {
            "pearls_pitfalls_en": "<p><span id=\"docs-internal-guid-e187751d-7fff-5895-4d63-329627b94a0c\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">More extensively validated in non-US populations.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Conditions such as acute hepatitis and acute cholangitis may have some similarities in presentation and should be excluded, as well as chronic cholecystitis.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Measurement of serum procalcitonin has <em>not</em> been shown to be useful for diagnosis or severity grading.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">If ultrasound is non-diagnostic, cholescintigraphy (HIDA) has a high sensitivity and specificity for diagnosis of acute cholecystitis. CT has low specificity.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Laparoscopic cholecystectomy (LC) to treat moderate- and severe-grade acute cholecystitis (Grades II and III) has better clinical outcomes at high volume centers.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">The guidelines recommend using the <calculator id=\"3917\">Charlson Comorbidity Index (CCI)</calculator> and <calculator id=\"10024\">ASA Physical Status</calculator> to stratify patients into low risk and high risk surgical candidates.</p>\n</li>\n</ul>",
            "use_case_en": "<p><span id=\"docs-internal-guid-46f2ae1b-7fff-1078-b5aa-fc5d6e207b43\">Use in patients with suspected acute cholecystitis (i.e., right upper quadrant tenderness, liver enzyme abnormalities, imaging findings characteristic of acute cholecystitis).</span></p>",
            "why_use_en": "<p><span id=\"docs-internal-guid-d5dea6e3-7fff-7ac4-bcf2-c03d497da0a2\">Objectively guides diagnosis and management of patients with acute cholecystitis in terms of early or delayed surgical intervention, early or delayed gallbladder drainage, and antibiotic choice and duration.</span></p>"
          },
          "next_steps": {
            "advice_en": "<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">If a definitive diagnosis cannot be made on presentation, it is reasonable to reassess the patient using the diagnostic criteria every 6-12 hours.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Early LC in 3-7 days is recommended for low risk candidates.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">For high risk candidates, percutaneous transhepatic gallbladder drainage should be considered. Endoscopic drainage (either via <abbr title=\"Endoscopic ultrasound\">EUS</abbr> or <abbr title=\"Endoscopic retrograde cholangiopancreatography\">ERCP</abbr>) can be considered in high volume centers.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Antibiotics should be chosen based on severity of disease, location of infection (community or hospital acquired), and local susceptibilities (see <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/29090866\" target=\"_blank\" rel=\"noopener\">Tokyo Guidelines 2018 Antimicrobial Therapy for Acute Cholangitis and Cholecystitis</a>).</p>\n</li>\n</ul>",
            "critical_actions_en": "",
            "management_en": "<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Grade I (mild):</p>\n</li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">LC should ideally be performed early after onset of symptoms for low risk patients based on the <calculator id=\"3917\">CCI</calculator> and <calculator id=\"10024\">ASA</calculator> scores.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">For high risk patients (<calculator id=\"3917\">CCI</calculator> &ge;6, <calculator id=\"10024\">ASA</calculator> &ge;3), conservative treatment can be considered initially (antibiotics, supportive care), with LC once clinical response achieved.</p>\n</li>\n</ul>\n</ul>\n<p><span id=\"docs-internal-guid-b5bf4107-7fff-ea55-a8e1-9ef2df2c62f6\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Grade II (moderate):</p>\n</li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">LC should ideally be performed early after onset of symptoms for low risk patients based on the <calculator id=\"3917\">CCI</calculator> and <calculator id=\"10024\">ASA</calculator>&nbsp;scores, preferably in a high volume center.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">In high risk patients (<calculator id=\"3917\">CCI</calculator> &ge;6, <calculator id=\"10024\">ASA</calculator> &ge;3), gallbladder drainage should be considered early with delayed/elective LC.</p>\n</li>\n</ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Grade III (severe):</p>\n</li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Resuscitative measures should be initiated at first with antibiotics, fluid resuscitation and vasopressor/respiratory support as needed.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">When considering LC, note negative predictive factors of neurological dysfunction, respiratory dysfunction, and co-existence of jaundice (total bilirubin &ge;2 mg/dL). In addition, scores of <calculator id=\"3917\">CCI</calculator> &ge;4 and <calculator id=\"10024\">ASA</calculator> &ge;3 suggest high risk for LC.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">If an adequate clinical response is achieved in low risk patients, early LC can be considered in a high volume expert center.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">In high risk patients, or all patients in low volume centers, early gallbladder drainage is recommended, especially if it is not possible to control gallbladder inflammation with initial treatment.</p>\n</li>\n</ul>\n</ul>"
          },
          "related_resources": {
            "guidelines": [],
            "interests": [],
            "mdcalc_rating": {
              "clinical": "",
              "evidence": "",
              "popularity": ""
            },
            "partner_contact": [],
            "sdm_tool": [],
            "teaching": [],
            "videos": []
          },
          "reviewer": []
        },
        "disabled": false,
        "disabled_reason": null,
        "disease_en": [
          "Cholecystitis"
        ],
        "dosing": false,
        "equation_logic": "c562d7c19e52e9d54c18c79dfa9ee0dd",
        "equation_logic_text": "var cardio = cardio || 0;\nvar neuro = neuro || 0;\nvar resp = resp || 0;\nvar renal = renal || 0;\nvar hep = hep || 0;\nvar hem = hem || 0;\nvar wbc18 = wbc18 || 0;\nvar mass18 = mass18 || 0;\nvar duration = duration || 0;\nvar local = local || 0;\n\nvar calc_output = [];\n\nvar parta = parseFloat(sign) + parseFloat(mass);\nvar partb = parseFloat(fever) + parseFloat(crp) + parseFloat(wbc);\nvar partc = parseFloat(image);\nvar grade3 = cardio + neuro + resp + renal + hep + hem;\nvar grade2 = wbc18 + mass18 + duration + local;\n\nvar diag, severity, risk, grade, msg;\n\nif ((parta > 0 && partb > 0 && partc == 0) || (parta > 0 && partb == 0 && partc > 0)) {\n  diag = 'Suspected';\n  if (grade3 > 0) {\n    severity = 'Severe';\n    grade = 'III';\n    risk = '5.4';\n  } else if (grade2 > 0) {\n    severity = 'Moderate';\n    risk = '0.8';\n    grade = 'II';\n  } else { \n    severity = 'Mild';\n    risk = '1.1';\n    grade = 'I';\n  }\n  msg = 'Diagnosis of acute cholecystitis';\n} else if (parta > 0 && partb > 0 && partc > 0) {\n  diag = 'Definite';\n  if (grade3 > 0) {\n    severity = 'Severe';\n    grade = 'III';\n    risk = '5.4';\n  } else if (grade2 > 0) {\n    severity = 'Moderate';\n    risk = '0.8';\n    grade = 'II';\n  } else { \n    severity = 'Mild';\n    risk = '1.1';\n    grade = 'I';\n  }\n  msg = 'Diagnosis of acute cholecystitis';\n} else {\n  diag = '';\n  msg = 'Entry criteria not met for acute cholecystitis diagnosis';\n}\n\n//results\nif(parta > 0 && (partb > 0 || partc > 0)){\ncalc_output.push({\n    name: 'mini',\n    value: diag,\n    value_text: '',\n    message: 'Grade ' + grade\n});\n} else {\ncalc_output.push({\n    name: 'mini',\n    value: '',\n    value_text: '',\n    message: msg\n});}\ncalc_output.push({\n    name: 'diag',\n    value: diag,\n    value_text: '',\n    message: msg\n});\nif(parta > 0 && (partb > 0 || partc > 0)){\ncalc_output.push({\n    name: 'grade',\n    value: 'Grade ' + grade,\n    value_text: '',\n    message: severity + ' acute cholecystitis<br/><br/>' + risk + '% 30-day mortality' \n});\n}\n",
        "favorite_id": 10130,
        "full_title_en": "Tokyo Guidelines for Acute Cholecystitis 2018",
        "input_schema": [
          {
            "inct": null,
            "option_fhir_rules": null,
            "subheading": "Part A: Local Signs of Inflammation",
            "subheading_instructions": "",
            "type": "subheading"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Murphy's sign",
            "md_calc_info_concept": null,
            "name": "sign",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Right upper abdominal quadrant mass, pain, or tenderness",
            "md_calc_info_concept": null,
            "name": "mass",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "inct": null,
            "option_fhir_rules": null,
            "subheading": "Part B: Systemic Signs of Inflammation",
            "subheading_instructions": "",
            "type": "subheading"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Fever",
            "md_calc_info_concept": null,
            "name": "fever",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Elevated CRP",
            "md_calc_info_concept": null,
            "name": "crp",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Elevated WBC count",
            "md_calc_info_concept": null,
            "name": "wbc",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "inct": null,
            "option_fhir_rules": null,
            "subheading": "Part C: Imaging",
            "subheading_instructions": "",
            "type": "subheading"
          },
          {
            "conditionality": "",
            "default": 0,
            "label_en": "Imaging findings characteristic of acute cholecystitis",
            "md_calc_info_concept": null,
            "name": "image",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "e.g. pericholecystic fluid, gallstones/debris",
            "type": "toggle"
          },
          {
            "inct": null,
            "option_fhir_rules": null,
            "subheading": "Grading",
            "subheading_instructions": "",
            "type": "subheading"
          },
          {
            "conditionality": "(sign + mass) > 0 && ((fever + crp + wbc) > 0 || image > 0)",
            "default": 0,
            "label_en": "Cardiovascular dysfunction",
            "md_calc_info_concept": null,
            "name": "cardio",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "Hypotension requiring treatment with dopamine ≥5 μg/kg per min or any dose of norepinephrine",
            "type": "toggle"
          },
          {
            "conditionality": "(sign + mass) > 0 && ((fever + crp + wbc) > 0 || image > 0)",
            "default": 0,
            "label_en": "Neurological dysfunction",
            "md_calc_info_concept": null,
            "name": "neuro",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "Decreased level of consciousness",
            "type": "toggle"
          },
          {
            "conditionality": "(sign + mass) > 0 && ((fever + crp + wbc) > 0 || image > 0)",
            "default": 0,
            "label_en": "Respiratory dysfunction",
            "md_calc_info_concept": null,
            "name": "resp",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "PaO<sub>2</sub>/FiO<sub>2</sub> ratio <300",
            "type": "toggle"
          },
          {
            "conditionality": "(sign + mass) > 0 && ((fever + crp + wbc) > 0 || image > 0)",
            "default": 0,
            "label_en": "Renal dysfunction",
            "md_calc_info_concept": null,
            "name": "renal",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "Oliguria or creatinine >2.0 mg/dL",
            "type": "toggle"
          },
          {
            "conditionality": "(sign + mass) > 0 && ((fever + crp + wbc) > 0 || image > 0)",
            "default": 0,
            "label_en": "Hepatic dysfunction",
            "md_calc_info_concept": null,
            "name": "hep",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "<abbr title = \"Prothrombin time test\">PT‐INR</abbr> >1.5",
            "type": "toggle"
          },
          {
            "conditionality": "(sign + mass) > 0 && ((fever + crp + wbc) > 0 || image > 0)",
            "default": 0,
            "label_en": "Hematological dysfunction",
            "md_calc_info_concept": null,
            "name": "hem",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "Platelet count <100,000/mm<sup>3</sup>",
            "type": "toggle"
          },
          {
            "conditionality": "(sign + mass) > 0 && ((fever + crp + wbc) > 0 || image > 0)",
            "default": 0,
            "label_en": "Elevated WBC count",
            "md_calc_info_concept": null,
            "name": "wbc18",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": ">18,000/mm<sup>3</sup>",
            "type": "toggle"
          },
          {
            "conditionality": "(sign + mass) > 0 && ((fever + crp + wbc) > 0 || image > 0)",
            "default": 0,
            "label_en": "Palpable tender mass in the right upper abdominal quadrant",
            "md_calc_info_concept": null,
            "name": "mass18",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "conditionality": "(sign + mass) > 0 && ((fever + crp + wbc) > 0 || image > 0)",
            "default": 0,
            "label_en": "Duration of complaints >72 hours",
            "md_calc_info_concept": null,
            "name": "duration",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "toggle"
          },
          {
            "conditionality": "(sign + mass) > 0 && ((fever + crp + wbc) > 0 || image > 0)",
            "default": 0,
            "label_en": "Marked local inflammation",
            "md_calc_info_concept": null,
            "name": "local",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "Gangrenous cholecystitis, pericholecystic abscess, hepatic abscess, biliary peritonitis, emphysematous cholecystitis",
            "type": "toggle"
          }
        ],
        "instructions_en": "",
        "isVisibleInListView": true,
        "logic_language": "javascript",
        "md5": "1364aa6d237a1a2ae491f60b78c90c4c",
        "medium_description_en": "<p><span id=\"docs-internal-guid-21529dff-7fff-2c70-b4de-fd0bd3116dfb\">Provides diagnostic criteria and severity grading for acute cholecystitis.</span></p>",
        "publishedAt": "2022-04-21T20:28:23.125Z",
        "purpose_en": [
          "Diagnosis"
        ],
        "replacement_calc_id": null,
        "search_abbreviation_en": [
          "laparoscopic cholecystectomy",
          "gallbladder inflammation",
          "gallbladder",
          "Cholecystectomy"
        ],
        "search_id": "c-10130",
        "seo": {
          "keywords_en": "Cholecystectomy, laparoscopic cholecystectomy, gallbladder, gallbladder inflammation",
          "meta_description_en": "The Tokyo Guidelines for Diagnosis and Severity Grading of Acute Cholecystitis provides diagnostic criteria and severity grading for acute cholecystitis."
        },
        "short_description_en": "<p>Acute cholecystitis diagnosis and grading.</p>",
        "short_title_en": "Tokyo Cholecystitis Guidelines",
        "slug": "tokyo-guidelines-acute-cholecystitis-2018",
        "specialty_en": [
          "Critical Care",
          "Gastroenterology",
          "Hospitalist Medicine",
          "Internal Medicine",
          "Surgery (General)"
        ],
        "system_en": [
          "Gastrointestinal"
        ],
        "tags": [],
        "versionNumber": 1,
        "versions": [],
        "vuid": "8a304016-7621-4598-ad23-70784376b997"
      },
      "contributors": [
        {
          "contributors_page": false,
          "description": "<p>Joseph Mizrahi, MD, is an internal medicine resident at Stony Brook University Hospital in New York. Born and raised in Brooklyn, New York, Dr. Mizrahi received his medical degree from the Sackler School of Medicine at Tel Aviv University, and he is also currently a student at the School of Public Health at Stony Brook University. Dr. Mizrahi's areas of interest include gastroenterology and colorectal cancer prevention and screening.</p>",
          "firstName": "Joseph",
          "hasDisclosure": [],
          "img": "joseph-mizrahi.jpg",
          "lastName": "Mizrahi",
          "name": "Joseph Mizrahi, MD",
          "signedCOI": true,
          "status": "Current",
          "target": "joseph-mizrahi"
        }
      ],
      "creators": [
        {
          "about_en": "Masamichi Yokoe, MD, is a physician in the internal medicine department at Nagoya Daini Red Cross Hospital in Honshu, Japan. Dr. Yokoe's primary research is focused on management of acute cholangitis and cholecystitis.",
          "deceased": false,
          "description": "",
          "firstName": "",
          "img": "",
          "lastName": "",
          "name": "Dr. Masamichi Yokoe",
          "photo_en": "",
          "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Yokoe%20M%5BAuthor%5D&cauthor=true&cauthor_uid=22872303",
          "signedCOI": false
        }
      ],
      "envs": {
        "CANONICAL_URL_ROOT": "https://www.mdcalc.com",
        "CONTENT_SERVER_TAG": "WEB_PROD",
        "RECAPTCHA_PUBLIC_KEY": "6Lcu1mMkAAAAAAwmSDO3I7JNaUo9YtZ3jnrzTP6a",
        "STRIPE_PUB_KEY": "pk_live_yYm2UzDzaudhFgqWcKbv9vH7"
      },
      "faqs": [
        {
          "cme_faq": {
            "answer": "<p>MDCalc&rsquo;s Continuing Medical Education (CME) service allows users to easily earn AMA PRA Category 1 CreditsTM through regular use of MDCalc. Simply put, on top of getting the best medical calculators in the world, your usage will help you achieve your annual CME requirements, including specialty CME, without any extra effort.</p>",
            "question": "What is MDCalc CME?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Yes, in support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MDCalc Ltd. Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p>",
            "question": "Is MDCalc CME accredited?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Only United States attending physicians, nurse practitioners, nurses, and physician assistants are eligible for our CME service.</p>",
            "question": "Who can enroll and how?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>We have over 275 CME-eligible calculators across various specialties. You can read the clinical content supporting any CME calculators to start earning. Once you have viewed all the supporting content for a calculator, you will have officially earned the credit amount (0.5 credits) and will be able to redeem a certificate. For now, only calc content in CME-eligible calcs is eligible for CME credits, however, we&rsquo;ll be expanding our CME service to include more of our content in the future.</p>",
            "question": "What activities can I do to earn CME credits?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Simply use our search bar or visit our homepage to easily find CME-eligible calcs. You must be enrolled in our CME service to see which calcs are CME-eligible.</p>",
            "question": "Where can I find calcs with which I can earn credits?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Once you&rsquo;ve enrolled in our CME service, you will have a personal CME Dashboard where you can view all of your earned credits. You can navigate to the dashboard by clicking the CME button in the header at the top of any page.</p>",
            "question": "Where can I see which credits I’ve earned?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Go to your CME Dashboard and select the credits you&rsquo;d like to redeem, fill out a few dropdown answers about how you used the calc, and then proceed to checkout.</p>",
            "question": "How do I redeem CME credits?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>No. Earning credits as you use calcs is free, but either you (or your employer) will need to purchase an annual subscription to redeem your CME certificates.</p>",
            "question": "Are CME credits free?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Just like with earned credits, you can view your CME certificates on your CME Dashboard in the &ldquo;CME Certificates&rdquo; tab. Certificates include a list of all of the calcs for which CME was earned along with a tally of the specialty CME.</p>",
            "question": "Where can I see my CME certificates?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>One year from the date of purchase.</p>",
            "question": "How long do credits in an annual subscription last?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>General; Addiction and Controlled Substances; Cardiac Care; Domestic and Intimate Partner Violence; Geriatrics; HIV and Infectious Disease; Hospice, End-of-Life, Terminal Illness, and Palliative Care; Mental and Behavioral Health; Pain Management; Pediatrics; Stroke; and Trauma.</p>",
            "question": "What specialty CME credits are included in the plan?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Your gift card will be sent via email within 1-2 business days of making your purchase. You will be able to select from the following options - Visa, Amazon.com, Apple. Be sure to claim your gift card offer within 90 days of receiving the email.</p>\n<p>Your CME purchase may have implications for tax reporting purposes. The cost of your CME product may or may not be tax-deductible when used for professional purposes. Any reimbursed amount for incentives must be declared as personal income for tax purposes. Please consult your tax advisor. MDCalc does not provide tax advice.</p>",
            "question": "I ordered a CME package with a gift card. How does it work?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Per the new guidelines from ACCME, the receipt will separate the cost you paid into the cost of the gift card and the cost of the CME learning activity.</p>",
            "question": "What will show on my receipt for CME when it includes a gift card?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can get a refund (minus any promotional gift amount) within 30-days if the ease of earning and redeeming does not meet your expectations and if you have redeemed no more than 4 credits. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request a refund.</p>",
            "question": "How do I get a refund if I'm not satisfied?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can upgrade your subscription throughout your billing cycle and pay the difference for a higher plan. You may request to downgrade your plan to a lower level to coincide with your next renewal. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request changes.</p>",
            "question": "How do I later upgrade to a different plan if I need more credits?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Gift card plans are available for 1 year and do not auto-renew. Standard, non gift-card subscriptions are auto-renewed annually. You can disable the automatic renewal of your subscription at any time by emailing <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a>.</p>",
            "question": "Do CME plans auto-renew?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>If you&rsquo;re part of a team or practice that wants to sign up five or more physicians, please email us at <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> for more information.</p>",
            "question": "How do I get information on a discounted bulk subscription program for my institution, team, or practice?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>On July 28, 2022, ACCME updated the guidelines regarding the use of high-value incentives. These guidelines allow for the use of gift card rewards in a regulated manner. Visit the ACCME website to read their guidelines.</p>",
            "question": "Did the ACCME decide to regulate gift cards?",
            "type": "Purchasing"
          }
        }
      ],
      "headConfig": {
        "canonicalUrl": "/calc/10130/tokyo-guidelines-acute-cholecystitis-2018",
        "description": "The Tokyo Guidelines for Diagnosis and Severity Grading of Acute Cholecystitis provides diagnostic criteria and severity grading for acute cholecystitis.",
        "keywords": "Cholecystectomy, laparoscopic cholecystectomy, gallbladder, gallbladder inflammation",
        "title": "Tokyo Guidelines for Acute Cholecystitis 2018"
      },
      "isCMECalc": true,
      "measurements": [],
      "relCalcs": [
        {
          "calcId": 10320,
          "short_title_en": "Rome IV for Gallbladder Disorder",
          "slug": "rome-iv-diagnostic-criteria-functional-gallbladder-disorder"
        },
        {
          "calcId": 3917,
          "short_title_en": "Charlson Comorbidity Index",
          "slug": "charlson-comorbidity-index-cci"
        },
        {
          "calcId": 10024,
          "short_title_en": "ASA Physical Status",
          "slug": "asa-physical-status-asa-classification"
        }
      ],
      "societies": {
        "American Association for the Study of Liver Diseases": {
          "abbreviation": "AASLD",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.aasld.org/"
        },
        "American College Of Emergency Physicians": {
          "abbreviation": "ACEP",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/american-college-of-emergency-physicians-squarelogo.png",
          "web_link": "https://www.acep.org/"
        },
        "American College of Gastroenterology": {
          "abbreviation": "ACG",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/acg_logo.png",
          "web_link": "https://gi.org/"
        },
        "American College of Rheumatology": {
          "abbreviation": "ACR",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.rheumatology.org/"
        },
        "American Gastroenterological Association": {
          "abbreviation": "AGA",
          "description": "plain-text",
          "img": "https://apps.mdcalc.com/images/societies/aga.jpeg",
          "web_link": "https://gastro.org"
        },
        "American Heart Association": {
          "abbreviation": "AHA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/societies/+AHA+(American+Heart+Association).png",
          "target": "aha",
          "web_link": "http://www.heart.org/HEARTORG/"
        },
        "American Urological Association": {
          "abbreviation": "AUA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.auanet.org/"
        },
        "EB Medicine": {
          "abbreviation": "EB Medicine",
          "description": "EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.",
          "img": "https://cdn-web-img.mdcalc.com/other/eb_medicine-icon-only.jpg",
          "target": "eb-medicine",
          "web_link": "http://www.ebmedicine.net/"
        },
        "MDCalc CME": {
          "abbreviation": "MDCalc CME",
          "img": "https://cdn-web-img.mdcalc.com/Stroke-CME-content.jpg",
          "web_link": "https://www.mdcalc.com/stroke-cme?utm_source=NIHSS_calc&utm_medium=NIHSS_calc&utm_campaign=NIHSS_calc"
        },
        "OTHER": {
          "abbreviation": "OTHER"
        },
        "Postgraduate Institute for Medicine": {
          "abbreviation": "PIM",
          "description": "plain-text",
          "img": "https://cdn-web-img.mdcalc.com/PIM-circle-COLOR.jpeg",
          "target": "pim",
          "web_link": "https://www.pimed.com/"
        },
        "VACO Podcast": {
          "description": "Listen to the VACO co-creators break down how to use VACO\\, what it does\\, and what it doesn’t.",
          "img": "https://cdn-web-img.mdcalc.com/content/podcast 2.png",
          "web_link": "https://www.stimuluspodcast.com/post/32-the-covid-mortality-score-vaco"
        }
      },
      "validSections": [
        "whenToUseViewed",
        "pearlsPitfallsViewed",
        "whyUseViewed",
        "nextStepsViewed",
        "evidenceViewed"
      ]
    }
  },
  "query": {
    "slug": [
      "10130",
      "tokyo-guidelines-acute-cholecystitis-2018"
    ]
  },
  "scriptLoader": []
}